[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9201425D0 - Method and means for preventing constriction of the pupil in the eye - Google Patents

Method and means for preventing constriction of the pupil in the eye

Info

Publication number
SE9201425D0
SE9201425D0 SE9201425A SE9201425A SE9201425D0 SE 9201425 D0 SE9201425 D0 SE 9201425D0 SE 9201425 A SE9201425 A SE 9201425A SE 9201425 A SE9201425 A SE 9201425A SE 9201425 D0 SE9201425 D0 SE 9201425D0
Authority
SE
Sweden
Prior art keywords
eye
pupil
preventing
antagonists
fragments
Prior art date
Application number
SE9201425A
Other languages
English (en)
Inventor
B Almegaard
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9201425A priority Critical patent/SE9201425D0/sv
Publication of SE9201425D0 publication Critical patent/SE9201425D0/sv
Priority to AU40311/93A priority patent/AU4031193A/en
Priority to PCT/SE1993/000391 priority patent/WO1993021911A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9201425A 1992-05-06 1992-05-06 Method and means for preventing constriction of the pupil in the eye SE9201425D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9201425A SE9201425D0 (sv) 1992-05-06 1992-05-06 Method and means for preventing constriction of the pupil in the eye
AU40311/93A AU4031193A (en) 1992-05-06 1993-05-05 Method and means for preventing constriction of the pupil in the eye
PCT/SE1993/000391 WO1993021911A1 (en) 1992-05-06 1993-05-05 Method and means for preventing constriction of the pupil in the eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201425A SE9201425D0 (sv) 1992-05-06 1992-05-06 Method and means for preventing constriction of the pupil in the eye

Publications (1)

Publication Number Publication Date
SE9201425D0 true SE9201425D0 (sv) 1992-05-06

Family

ID=20386161

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201425A SE9201425D0 (sv) 1992-05-06 1992-05-06 Method and means for preventing constriction of the pupil in the eye

Country Status (3)

Country Link
AU (1) AU4031193A (sv)
SE (1) SE9201425D0 (sv)
WO (1) WO1993021911A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003993A2 (en) * 1994-08-05 1996-02-15 The Rockefeller University Modulation of thymocyte and t cell functional activity
AUPM771894A0 (en) * 1994-08-29 1994-09-22 Royal Children's Hospital Research Foundation Method for the treatment of indirect inguinal hernias and related conditions
US6416760B2 (en) 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2729855A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2732222B1 (fr) 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour le traitement des prurits et des dysesthesies oculaires et palpebraux
FR2732221B1 (fr) 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
FR2732220B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat

Also Published As

Publication number Publication date
WO1993021911A1 (en) 1993-11-11
AU4031193A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
MY106315A (en) Pharmaceutical agents
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ES2030124T3 (es) Dispositivo para la aplicacion de implantes.
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
AP9901655A0 (en) Controlled release of pharmaceuticals in the anterior chamber of the eye.
FI962154A (sv) Komposition för in vivo framställning av terapeutiska produkter
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
LU90935I2 (en) Azopt-brinzolamide
DE69333023D1 (de) 3-beta-hydroxylierte natürliche Steroidderivate enthaltende Arzneimittelzusammensetzungen und ihre Verwendung
AU5567790A (en) Device for reinforcing and sustaining the cap of the rotators of a human shoulder joint
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
PL313075A1 (en) Heterocyclic compounds used as antagonistic substances in respect to neurokinin
DK0664133T3 (da) "Ostim Apatit"-præparat til stimulering af vækst i knoglevæv
MX9203667A (es) Sales de bis-dimetoximetil (trimetoxibencil)quinolino, su preparacion y composicines farmaceuticas que las contienen.
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
AU3078892A (en) Human interleukin-8 analogs
SE8602241D0 (sv) Hudregenererande och hydratiserande kosmetiska kompositioner och forfarande for framstellning av den aktiva ingrediensen
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
SE9201425D0 (sv) Method and means for preventing constriction of the pupil in the eye
IL65141A0 (en) Substituted 3-amino-sydnonimines and salts thereof,their preparation and pharmaceutical compositions containing them
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
AU3658793A (en) Bimodal molecular weight hyaluronate formulations and methods for using same
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
GB9718568D0 (en) Compositions